Fundraising Fox

Venostent

YC S20 ↗

Houston, US · Founded 2017 · Delaware corporation · 17 employees · 9 known investors

venostent.com ↗

SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.

BiotechDigital HealthHealthtechMedical Devices3D Printingin /venostent@venostentycombinator.com ↗

Founders & leadership· Y Combinator alumni (S20)

TBTim Boire
Tim BoireinFounder
GLGeoffrey Lucks
Geoffrey LucksinFounder
JW
Joel WhitleyDirector
JM
Jim MonsorDirector
RC
Robert CrutchfieldDirector

Investors · 9

Creative VenturesSan Francisco Bay Area · $1M
Good Growth CapitalCharleston
Health WildcattersDallas
Kube VC
Texas HALO FundHouston
TMC Venture FundHouston
Wealthing VC ClubPalo Alto
Y CombinatorSan Francisco · $500K
Good Life Sciences GenerationsreportedCharleston

Reported raises · per SEC filings

Form D private placements
▶$10MraisedMay 2026 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey LucksExecutive Officer, Director
  • Joel WhitleyDirector
  • Timothy BoireExecutive Officer, Director
  • Jim MonsorDirector
  • Robert CrutchfieldDirector
Offering amount
$10M
Amount sold
$10M
Minimum investment
$10K
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.1MraisedJul 2023 · 60 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel WhitleyDirector
  • Timothy BoireExecutive Officer, Director
  • Jim MonsorDirector
  • Geoffrey LucksExecutive Officer, Director
  • Robert CrutchfieldDirector
Offering amount
$21.2M
Amount sold
$16.1M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedFeb 2021 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy BoireExecutive Officer, Director
  • Kulika WeizmanDirector
  • Geoffrey LucksExecutive Officer, Director
Offering amount
$3M
Amount sold
$2.2M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$515KraisedJun 2020 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey LucksExecutive Officer, Director
  • Timothy BoireExecutive Officer, Director
Offering amount
$535K
Amount sold
$515K
First sale
May 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$263.9KraisedJul 2019 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey LucksExecutive Officer, Director
  • Timothy BoireExecutive Officer, Director
Offering amount
$300K
Amount sold
$263.9K
Minimum investment
$10K
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70KraisedMar 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey LucksExecutive Officer, Director
  • Timothy BoireExecutive Officer, Director
Offering amount
$400K
Amount sold
$70K
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news